Agile Therapeutics Inc Коэффициент "короткого" интереса
Что обозначает Коэффициент "короткого" интереса в Agile Therapeutics Inc?
Коэффициент "короткого" интереса Agile Therapeutics Inc является 1.33
Какое определение для Коэффициент "короткого" интереса?
Краткосрочный коэффициент - это количество проданных акций, которых нет в наличии, деленное на среднесуточный объем.
Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.
The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.
Коэффициент "короткого" интереса компаний в Health Care сектор на NASDAQ по сравнению с Agile Therapeutics Inc
Что делает Agile Therapeutics Inc?
agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.
Компании с коэффициент "короткого" интереса похож на Agile Therapeutics Inc
- Aluminum Of China имеет Коэффициент "короткого" интереса из 1.32
- Sun Metals имеет Коэффициент "короткого" интереса из 1.32
- Hailiang Education Inc имеет Коэффициент "короткого" интереса из 1.32
- Pinehurst Capital II имеет Коэффициент "короткого" интереса из 1.32
- Acerus Pharmaceuticals имеет Коэффициент "короткого" интереса из 1.32
- Newmont Corp имеет Коэффициент "короткого" интереса из 1.32
- Agile Therapeutics Inc имеет Коэффициент "короткого" интереса из 1.33
- Telefonica Brasil S.A имеет Коэффициент "короткого" интереса из 1.34
- Perpetual имеет Коэффициент "короткого" интереса из 1.34
- Immutep имеет Коэффициент "короткого" интереса из 1.34
- Boqii Ltd имеет Коэффициент "короткого" интереса из 1.34
- General Moly имеет Коэффициент "короткого" интереса из 1.34
- Bandwidth Inc имеет Коэффициент "короткого" интереса из 1.34